Prostate-specific antigen and risk of bone metastases in west Africans with prostate cancer.

Amoako, Yaw Ampem; Hammond, Emmanuel Nii Boye; Assasie-Gyimah, Awo; Laryea, Dennis Odai; Ankrah, Alfred; Amoah, George

Amoako, Yaw Ampem; Hammond, Emmanuel Nii Boye; Assasie-Gyimah, Awo; Laryea, Dennis Odai; Ankrah, Alfred; Amoah, George.

Afiliación

Amoako YA; Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana, West Africa.
Hammond ENB; Department of Nuclear Medicine Service, Korle Bu Teaching Hospital, Accra, Ghana, West Africa.
Assasie-Gyimah A; Department of Ghana Atomic Energy Commission, Accra, Ghana, West Africa.
Laryea DO; Department of Nuclear Medicine Service, Korle Bu Teaching Hospital, Accra, Ghana, West Africa.
Ankrah A; Department of Non Communicable Disease Control Programme, Ghana Health Service Headquarters, Accra, Ghana, West Africa.
Amoah G; Department of Nuclear Medicine Service, Korle Bu Teaching Hospital, Accra, Ghana, West Africa.

World J Nucl Med ; 18(2): 143-148, 2019.

Article en En | MEDLINE | ID: mdl-31040745

Palabras clave

Bone scintigraphy; Ghana; Gleason score; prostate cancer; prostate-specific antigen

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: World J Nucl Med Año: 2019 Tipo del documento: Article Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google